215 related articles for article (PubMed ID: 38252229)
21. Towards a Diagnosis of Cardiac Amyloidosis: Single Center Experience with
Saleem M; Sadat B; Van Harn M; Ananthasubramaniam K
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837580
[No Abstract] [Full Text] [Related]
22. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
[TBL] [Abstract][Full Text] [Related]
23. Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive
Nishi M; Takashio S; Morioka M; Fujiyama A; Nakashima N; Hirakawa K; Hanatani S; Usuku H; Yamamoto E; Kidoh M; Oda S; Gushima R; Matsushita K; Fukushima S; Ueda M; Tsujita K
Circ J; 2022 Jun; 86(7):1113-1120. PubMed ID: 35599006
[TBL] [Abstract][Full Text] [Related]
24. Inter-observer reproducibility and intra-observer repeatability in
Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
[TBL] [Abstract][Full Text] [Related]
26. Cardiac [
Tingen HSA; Tubben A; Bijzet J; van den Berg MP; van der Meer P; Houwerzijl EJ; Muntinghe FLH; van der Zwaag PA; Glaudemans AWJM; Oerlemans MIFJ; Knackstedt C; Michels M; Hirsch A; Hazenberg BPC; Slart RHJA; Nienhuis HLA
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):681-690. PubMed ID: 37843599
[TBL] [Abstract][Full Text] [Related]
27. A Gluteus Medius Muscle Biopsy to Confirm Amyloid Transthyretin Deposition in Wild-type Transthyretin Cardiac Amyloidosis: A Report of Two Cases.
Takahashi K; Iwamura T; Hiratsuka Y; Sasaki D; Yamamura N; Ueda M; Morioka H; Yoshino M; Enomoto D; Uemura S; Okura T; Sakaue T; Ikeda S
Intern Med; 2024 Jun; 63(11):1575-1584. PubMed ID: 37899242
[TBL] [Abstract][Full Text] [Related]
28. Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.
Lee TH; Wang YF; Hu LH; Peng NJ; Chang CY; Huang WS
Jpn J Radiol; 2023 Aug; 41(8):882-888. PubMed ID: 36920732
[TBL] [Abstract][Full Text] [Related]
29. Bilateral Multiple Fractures Obstruct Quantitation of 99m Tc-Pyrophosphate Imaging for Cardiac Amyloidosis.
Zhou Q; Zuo J; Xiao L; Jiang L; Zhao Z
Clin Nucl Med; 2024 Jul; 49(7):e362-e363. PubMed ID: 38651782
[TBL] [Abstract][Full Text] [Related]
30. Estimating cancer risk from
Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972
[TBL] [Abstract][Full Text] [Related]
31. Cardiac sympathetic denervation in wild-type transthyretin amyloidosis.
Gimelli A; Aimo A; Vergaro G; Genovesi D; Santonato V; Kusch A; Emdin M; Marzullo P
Amyloid; 2020 Dec; 27(4):237-243. PubMed ID: 32441155
[TBL] [Abstract][Full Text] [Related]
32. Quantitative single photon emission computed tomography derived standardized uptake values on 99mTc-PYP scan in patients with suspected ATTR cardiac amyloidosis.
Avalon JC; Fuqua J; Deskins S; Miller T; Conte J; Martin D; Marano G; Yanamala N; Mills J; Bianco C; Patel B; Seetharam K; Raylman R; Sengupta PP; Hamirani YS
J Nucl Cardiol; 2023 Feb; 30(1):127-139. PubMed ID: 35655113
[TBL] [Abstract][Full Text] [Related]
33. Low-sensitivity 99mTc pyrophosphate scintigraphy for hereditary transthyretin cardiac amyloidosis with Glu112Lys genotype.
Deng Y; Pan R; Guo Y; Wang X; Tian Z
Eur Heart J Cardiovasc Imaging; 2024 Feb; 25(3):e115. PubMed ID: 37956103
[No Abstract] [Full Text] [Related]
34. Volumetric evaluation of
Watanabe S; Nakajima K; Wakabayashi H; Yoneyama H; Yoshida S; Komatsu J; Konishi T; Inaki A; Kinuya S
J Nucl Cardiol; 2022 Dec; 29(6):3102-3110. PubMed ID: 34907500
[TBL] [Abstract][Full Text] [Related]
35. Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Castaño A; Bokhari S; Brannagan TH; Wynn J; Maurer MS
Amyloid; 2012 Mar; 19(1):41-6. PubMed ID: 22149423
[TBL] [Abstract][Full Text] [Related]
36.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
37. A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Kavita A; Abdul Onny MA; Suppiah S; Abdul Aziz AF; Hashim H; Raja Shariff RE; Ng CS
Med J Malaysia; 2021 Sep; 76(5):762-767. PubMed ID: 34508392
[TBL] [Abstract][Full Text] [Related]
38. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.
Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M
J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of quantitative
Ogasawara K; Shiraishi S; Tsuda N; Sakamoto F; Oda S; Takashio S; Tsujita K; Hirai T
Jpn J Radiol; 2022 May; 40(5):508-517. PubMed ID: 34973114
[TBL] [Abstract][Full Text] [Related]
40. Optimizing cardiac amyloidosis assessment: utility of 1-h and 3-h
Imakhanova A; Ideguchi R; Kawano H; Maemura K; Kudo T
Eur J Med Res; 2024 Jan; 29(1):32. PubMed ID: 38184638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
